BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19175140)

  • 1. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "An experimental palladium-103 seed (OptiSeedexp in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect" [Med. Phys. 35, 5841-5850 (2008)].
    Pignol JP; Keller BM
    Med Phys; 2009 Jun; 36(6):2343; author reply 2344. PubMed ID: 19610324
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
    Abboud F; Hollows M; Scalliet P; Vynckier S
    Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric study of the new Intersource125 iodine seed.
    Reniers B; Vynckier S; Scalliet P
    Med Phys; 2001 Nov; 28(11):2285-8. PubMed ID: 11764034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements.
    Reniers B; Verhaegen F; Vynckier S
    Phys Med Biol; 2004 Apr; 49(8):1569-82. PubMed ID: 15152693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
    Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
    Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
    Khan S; Chen ZJ; Nath R
    Med Phys; 2008 Apr; 35(4):1403-6. PubMed ID: 18491535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
    Sadeghi M; Raisali G; Hosseini SH; Shavar A
    Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
    Sadeghi M; Hosseini SH; Raisali G
    Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.